Skip to main content
Clinical Trials/NCT05195073
NCT05195073
Completed
Not Applicable

Three Dimensional Versus Two-dimensional Laparoscopic Salpingectomy in Patients With Hydrosalpinx Undergoing IVF-ET. A Randomized Controlled Trial

Cairo University1 site in 1 country36 target enrollmentApril 1, 2022
ConditionsHydrosalpinx

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hydrosalpinx
Sponsor
Cairo University
Enrollment
36
Locations
1
Primary Endpoint
The time required to excise the hydrosalpinx
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

A three-dimensional laparoscopic vision system (3-D LVS) has gained acceptance and is being utilized in daily practice despite debates about its success.

Detailed Description

A three-dimensional laparoscopic vision system (3-D LVS) has gained acceptance and is being utilized in daily practice despite debates about its success. in our study we will compare operative data and early postoperative outcomes of laparoscopic salpingectomy operations conducted using standard 2-D and 3-D laparoscopic vision systems

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
December 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marwa Mohamed Abdalla

lecturer of Obstetrics and Gynecology

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patients with unilateral hydrosalpinx diagnosed with hysterosalpingography or laparoscopy

Exclusion Criteria

  • Bilateral hydrosalpinx,
  • co-existent adnexal pathology,
  • body mass index (BMI) more than 40,
  • extensive pelvic adhesions,
  • coagulation defects or concurrent anticoagulant therapy,
  • compromised cardiopulmonary status,
  • and contraindications for general anesthesia.

Outcomes

Primary Outcomes

The time required to excise the hydrosalpinx

Time Frame: 6 months

The time required to excise the hydrosalpinx

Secondary Outcomes

  • The total operative time.(6 months)
  • The amount of Intraoperative blood loss.(6 months)
  • Rate of intraoperative and postoperative complications.(6 months)
  • The degree of difficulty experienced by the surgeon(6 months)

Study Sites (1)

Loading locations...

Similar Trials